Analysed CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ) News Sources
Citius Oncology Provides Commercial Update on LYMPHIR™ Launch Highlighting Early Adoption and Expanding Clinical Development
31-03-2026
yahoo.com
Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
24-04-2026
yahoo.com
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
24-04-2026
yahoo.com
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
15-05-2026
yahoo.com
Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
15-05-2026
yahoo.com
Is Citius Pharmaceuticals, Inc. (CTXR) among the Best Rated Penny Stocks to Buy According to Wall Street Analysts?
24-05-2026
yahoo.com
What is the current price of CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ)?
The current price of CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ) is $0.6549.
CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ) absolute price change since previous trading day?
The absolute price change of CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ) since the previous trading day is $0.002.
CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ) percentage price change since previous trading day?
The percentage price change of CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ) since the previous trading day is 0.3063%.
What is the most recent average sentiment score for CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ)?
The most recent average sentiment score for CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ)?
The most recent sentiment for CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ) is .
SEC-8K** Filing Available For CITIUS PHARMACEUTICALS INC (CTXR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.